Profound Medical (TSE:PRN) Shares Down 4.1% - Should You Sell?

Key Points

• Profound Medical Corp. shares fell by 4.1%, trading at C$6.80, down from a previous close of C$7.09.
• The company operates as a commercial-stage medical device firm, specializing in incision-free therapeutic systems for the treatment of diseased tissue in multiple countries.
• Profound Medical has a market cap of C$204.36 million and its stock shows a negative PE ratio of -4.69.

Profound Medical Corp. (TSE:PRN - ) traded down 4.1% during mid-day trading on Tuesday . The stock traded as low as C$6.78 and last traded at C$6.80. 4,993 shares traded hands during trading, a decline of 46% from the average session volume of 9,187 shares. The stock had previously closed at C$7.09.

Profound Medical Stock Performance

The stock has a 50-day simple moving average of C$6.72 and a 200-day simple moving average of C$7.34. The company has a debt-to-equity ratio of 20.05, a current ratio of 6.12 and a quick ratio of 14.98. The stock has a market cap of C$204.36 million, a PE ratio of -4.69 and a beta of -0.25.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.